-
It’s crunch time for US biopharma M&A. Can drugmakers strike deals despite persisting anxieties?
15 Jan 2026 14:34 GMT
Between regulatory upheaval, drug pricing measures, an escalating … and more last year, drugmakers have had plenty of reasons … Anxiety drivers
Last year presented pharma leaders with a series of … country’s rapid ascent in biotech innovation, and U.S. …
-
Novo Nordisk Foundation pledges €736m for European biotech
15 Jan 2026 12:12 GMT
With attention in biotech focused on the JPM Healthcare … a controlling stake in Danish drugmaker Novo Nordisk – is providing the …
-
Alamo BioCenter’s BioSpark Program Celebrates Pilot-Year Success in Middle and High School Biotech Training
15 Jan 2026 13:56 GMT
Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling expansion in the year ahead.
SAN ANTONIO, TX, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- BioSpark, a San Antonio– …
-
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
15 Jan 2026 13:00 GMT
LAS VEGAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on the execution …
-
InSilico Lands Drug Discovery Deal After Hong Kong IPO
15 Jan 2026 11:50 GMT
… discovery of new cancer drugs.
The Chinese biotech announced last week that … its technology to non-pharmaceutical fields, but drug discovery and development account … and Fosun Pharma, as well as discovery partnerships with global drugmakers such …
-
Chicago Atlantic Provides $16.5 Million Term Loan to Ocular Science, Inc., a Leading Biotech Company Focused on Compounded Ophthalmic Products
15 Jan 2026 14:41 GMT
… affordable medication available to patients.
“Ocular Science is a leading biotech company … , Calif., is a leading biotech company founded in 2015 by … SERVICES HEALTH FINANCE GENERAL HEALTH PHARMACEUTICAL OPTICAL BIOTECHNOLOGY
SOURCE: Chicago Atlantic
Copyright …
-
Samsung Epis targets nine additional biosimilars, drug development expansion in growth strategy
15 Jan 2026 12:08 GMT
… business from biosimilar and new drug development.
The holding company oversees … tasked with advancing platform-based biotechnological innovations.
A view of Samsung … developing biosimilars for seven blockbuster drugs — defined as products with annual …
-
STAT+: On Day 3 of JPM, pharma threads a needle with the White House, and Novo Nordisk has an eye on M&A
15 Jan 2026 10:33 GMT
… DeAngelis is the East Coast biotech and venture capital reporter at … The Readout, STAT’s flagship biotech newsletter. Sign up to get … — not just as the Danish pharma company’s CEO, but ever … coverage and analysis of the biotech sector — by subscribing to STAT …
-
STAT+: Regeneron’s chief scientist on Trump’s drug pricing policy, gene therapy, and the problem with AI
15 Jan 2026 10:32 GMT
… ’s medicines, including the eye drug Eylea and Dupixent, an antibody … “most-favored nations” policy on drug pricing and why Regeneron is … coverage and analysis of the biotech sector — by subscribing to STAT …
-
Five things for pharma marketers to know for Thursday, January 15, 2025
15 Jan 2026 10:17 GMT
… since 2021. Stock sales from drug developers are off to a … 2026, boosting the prospects for biotechnology fundraising after turbulence in the … return to mid-single-digit pharma growth by 2027. The … edition of Five things for pharma marketers to know, click here …
About
© 1995-2026